Cargando…
High expression of TXNDC11 indicated unfavorable prognosis of glioma
BACKGROUND: Thioredoxin domain containing 11 (TXNDC11) has been implicated in numerous cancers. Nevertheless, the function of TXNDC11 in glioma is not well described. This study aimed to assess clinical significance of TXNDC11 in glioma based on bioinformatics analysis and immunohistochemical (IHC)...
Autores principales: | Peng, Peng, Cheng, Fangling, Dong, Yuting, Chen, Zirong, Zhang, Xiaolin, Guo, Dongsheng, Yu, Xingjiang, Lu, Yiyang, Ke, Yuyong, Zhang, Bin, He, Ximiao, Wan, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799221/ https://www.ncbi.nlm.nih.gov/pubmed/35116356 http://dx.doi.org/10.21037/tcr-21-1326 |
Ejemplares similares
-
SCAMP3 Promotes Glioma Proliferation and Indicates Unfavorable Prognosis via Multiple Pathways
por: Li, Chunliu, et al.
Publicado: (2020) -
TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma
por: Yu, Hao, et al.
Publicado: (2023) -
Clinical Value of TXNDC12 Combined With IDH and 1p19q as Biomarkers for Prognosis of Glioma
por: Wang, Xinzhuang, et al.
Publicado: (2021) -
Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation
por: Chan, Mikko C., et al.
Publicado: (2021) -
Homeobox A11 hypermethylation indicates unfavorable prognosis in breast cancer
por: Xia, Bingshu, et al.
Publicado: (2016)